Skip to main content
Caplight Logo









Tissue Dynamics

Tissue Dynamics

Private
IsraelHealthcare & Life Scienceshttps://tissuedynamics.com

Last Round

Grant

Dec 19, 2023

Total Funding Raised

$1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tissue Dynamics is a biotechnology company that develops drug toxicity and efficacy screening tools using advanced organ-on-chip technology and artificial intelligence for the pharmaceutical and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

organ-on-chipOOCdrug toxicity screeningdrug discoverymicrophysiological systemsanimal-free testingin vitro modelsbionic organ-on-chipsafety pharmacologymetabolic reconstructionorganoid platformbiotech equipmentpredictive toxicologylab-on-a-chiphigh-throughput screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tissue Dynamics Comparables

Compare Tissue Dynamics with similar companies based on industry and business-model similarity.

Tissue Dynamics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlveoliX AG
88%
TissUse
88%
Dynamic42
86%

Tissue Dynamics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 19, 2023
Series AJun 3, 2022
SeedJul 28, 2020

Key People

Founding team and executive leadership

Avner Ehrlich

Chief Technology Officer

Executive Team

Tissue Dynamics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 788% MoM, from 32 to 284.

  • Jul 19, 2026

    Grew 25% QoQ, from 24 to 30 employees.

Tissue Dynamics Filings

Explore SEC and related filing metadata, where available.

Tissue Dynamics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tissue Dynamics's valuation, stock price, and market status.

Is Tissue Dynamics a public or private company?

Tissue Dynamics is a private company.

What is the current stock price of Tissue Dynamics?

Tissue Dynamics is a private company, so its shares have no public market price. Caplight tracks Tissue Dynamics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Tissue Dynamics worth (valuation)?

Valuation information for Tissue Dynamics is not publicly available.

Can I buy Tissue Dynamics stock?

Tissue Dynamics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Tissue Dynamics's last funding round?

Tissue Dynamics's most recent funding round was Grant on December 19, 2023.

Who are the main investors in Tissue Dynamics?

Key investors in Tissue Dynamics include AIR Capital, The Hebrew University of Jerusalem, Yissum Research Development Company of the Hebrew University of Jerusalem, European Research Council.

Will Tissue Dynamics IPO soon?

No public IPO plans have been announced for Tissue Dynamics.

How can I track Tissue Dynamics secondary market activity?

Caplight tracks bids, offers, and trades in Tissue Dynamics's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range24
Year Founded2017
Last FundingDec 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?